Royal Bank of Canada’s Summit Therapeutics SMMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$141K Buy
7,422
+4,226
+132% +$68.3K ﹤0.01% 4931
2025
Q4
$56K Sell
3,196
-182,617
-98% -$3.44M ﹤0.01% 5496
2025
Q3
$3.84M Buy
185,813
+99,319
+115% +$2.41M ﹤0.01% 2877
2025
Q2
$1.84M Buy
86,494
+84,613
+4,498% +$1.93M ﹤0.01% 3380
2025
Q1
$36K Sell
1,881
-1,918
-50% -$38.5K ﹤0.01% 5691
2024
Q4
$68K Sell
3,799
-106,135
-97% -$2.06M ﹤0.01% 5540
2024
Q3
$2.41M Buy
109,934
+93,189
+557% +$1.3M ﹤0.01% 2848
2024
Q2
$130K Buy
16,745
+5,288
+46% +$28.6K ﹤0.01% 5098
2024
Q1
$47K Sell
11,457
-21,838
-66% -$86.8K ﹤0.01% 5571
2023
Q4
$87K Buy
33,295
+13,816
+71% +$28.4K ﹤0.01% 5701
2023
Q3
$36K Buy
19,479
+7,331
+60% +$14K ﹤0.01% 5951
2023
Q2
$30K Buy
12,148
+11,524
+1,847% +$21K ﹤0.01% 6016
2023
Q1
$1K Sell
624
-1,969
-76% -$5.37K ﹤0.01% 6931
2022
Q4
$11K Buy
+2,593
New +$4.72K ﹤0.01% 6518
2022
Q2
Sell
-1,620
Closed -$4K 7684
2022
Q1
$4K Sell
1,620
-4,226
-72% -$10.7K ﹤0.01% 7336
2021
Q4
$15K Buy
5,846
+2,536
+77% +$12.2K ﹤0.01% 6920
2021
Q3
$17K Buy
3,310
+1,771
+115% +$12.7K ﹤0.01% 6774
2021
Q2
$11K Buy
1,539
+1,518
+7,229% +$9.96K ﹤0.01% 6844
2021
Q1
$0 Buy
+21
New +$135 ﹤0.01% 7662
2018
Q4
Sell
-11,000
Closed -$24K 7083
2018
Q3
$24K Sell
11,000
-900
-8% -$2.07K ﹤0.01% 5588
2018
Q2
$29K Hold
11,900
﹤0.01% 5391
2018
Q1
$154K Buy
11,900
+9,400
+376% +$117K ﹤0.01% 4464
2017
Q4
$28K Hold
2,500
﹤0.01% 5446
2017
Q3
$31K Hold
2,500
﹤0.01% 5707
2017
Q2
$28K Buy
+2,500
New +$28.1K ﹤0.01% 5408

Other funds holding SMMT